首页> 外国专利> COMBINATION THERAPY FOR TREATMENT OF DIABETES AND CONDITION RELATED THERETO AND FOR TREATMENT OF CONDITION AMELIORATED BY INCREASING BLOOD GLP-1 LEVEL

COMBINATION THERAPY FOR TREATMENT OF DIABETES AND CONDITION RELATED THERETO AND FOR TREATMENT OF CONDITION AMELIORATED BY INCREASING BLOOD GLP-1 LEVEL

机译:糖尿病及其相关病症的联合疗法以及通过提高血液GLP-1水平缓解的联合疗法

摘要

PPROBLEM TO BE SOLVED: To provide a composition and a method for treating or preventing diabetes and conditions related to diabetes and increasing blood GLP-1 level of mammals. PSOLUTION: The invention relates to a combination of a definite amount of a GPR119 agonist with a definite amount of a dipeptidyl peptidase IV (DPP-IV) inhibitor such that the combination provides an effect in lowering a blood glucose level or in increasing a blood GLP-1 level in a subject over that provided by the amount of the GPR119 agonist or the amount of the DPP-IV inhibitor alone, and the use of such a combination for treating or preventing diabetes and conditions related to diabetes or conditions ameliorated by increasing a blood GLP-1 level. PCOPYRIGHT: (C)2008,JPO&INPIT
机译:

要解决的问题:提供一种用于治疗或预防糖尿病和与糖尿病有关的病症并提高哺乳动物血液GLP-1水平的组合物和方法。解决方案:本发明涉及一定量的GPR119激动剂与一定量的二肽基肽酶IV(DPP-IV)抑制剂的组合,使得该组合具有降低血糖水平或增加血糖的作用。受试者的血液GLP-1水平超过GPR119激动剂的量或DPP-IV抑制剂的单独水平所提供的水平,以及这种组合在治疗或预防糖尿病以及与糖尿病有关的疾病或改善的疾病中的用途通过增加血液中的GLP-1水平。

版权:(C)2008,日本特许厅&INPIT

著录项

  • 公开/公告号JP2008110964A

    专利类型

  • 公开/公告日2008-05-15

    原文格式PDF

  • 申请/专利权人 ARENA PHARMACEUTICALS INC;

    申请/专利号JP20070232094

  • 申请日2007-09-06

  • 分类号A61K45/06;A61K31/4985;A61P43;A61P3/10;A61P9;A61P13/12;A61P25;A61P9/10;A61P3/06;A61P9/12;A61P27/12;A61P25/28;A61P25/16;C07D487/04;A61K31/444;C07D401/04;C12N15/09;

  • 国家 JP

  • 入库时间 2022-08-21 20:24:38

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号